Europe and Middle East & Africa Gastrointestinal Testing Panels Market: Introduction
Transparency Market Research delivers key insights on the gastrointestinal testing panels market Europe and Middle East & Africa. In terms of value, the gastrointestinal testing panels market in Europe and Middle East & Africa is projected to expand at a CAGR of 4.7% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the gastrointestinal testing panels market in Europe and Middle East & Africa.
Gastrointestinal testing panel is defined as a comprehensive panel designed to detect the most prevalent gastrointestinal diseases using a molecular technique. A gastrointestinal testing panel provides quick and accurate results for the healthcare provider to analyze and provide diagnosis based on the disease and severity.
Various pathogens that can be detected using gastrointestinal testing panels include Adenovirus Campylobacter jejuni, Campylobacter upsaliensis, Campylobacter coli, Clostridioides difficile Toxin A, Clostridioides difficile Toxin B, Helicobacter pylori, astrovirus, rotavirus, Salmonella spp, Norovirus GI, Norovirus GII, Enteroinvasive Escherichia coli, Enteroaggregative Escherichia coli, Enterotoxigenic Escherichia coli, Enterohemorrhagic Escherichia coli, Yersinia enterocolitica, Escherichia coli, and Endogenous Control.
Europe and Middle East & Africa Gastrointestinal Testing Panels Market: Dynamics
According to the U.S. Census Bureau, the geriatric population, people aged over 65 years, has increased significantly in the past few years, and is projected to account for over 16.7% of the global population by 2050. Prevalence of gastrointestinal disorders is common among the elderly, and around 65% of the geriatric population struggles with different kinds of gastrointestinal complications.
Europe and Middle East & Africa Gastrointestinal Testing Panels Market: Key Players
Major players operating in the gastrointestinal testing panels market in Europe and Middle East & Africa are Becton, Dickinson and Company (BD), vbioMérieux SA, DiaSorin S.p.A (Luminex), Quidel Corporation, QIAGEN, Seegene, Inc., Savyon Diagnostics, CerTest Biotech S.L., and Anatolia Geneworks. The companies mentioned are the leading players in the region as they provide various gastrointestinal testing panels.
-Ends-
Source: https://www.transparencymarketresearch.com/emea-gastrointestinal-testing-panels-market.html
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
